keyword
https://read.qxmd.com/read/38495131/effect-of-rituximab-on-immune-status-in-children-with-aggressive-mature-b-cell-lymphoma-leukemia-a-prospective-study-from-cccg-bnhl-2015
#21
JOURNAL ARTICLE
Jiajia Dong, Zhou Xu, Xia Guo, Fanghua Ye, Chenying Fan, Ju Gao, Yijin Gao, Liangchun Yang
BACKGROUND: Limited research has been conducted on the impact of rituximab on immune function and the incidence of side effects in children undergoing combination chemotherapy for aggressive mature B-cell lymphoma/leukemia. METHODS: Clinical data from 85 patients with primary pediatric aggressive mature B-cell lymphoma/leukemia, treated according to the Chinese Children's Cancer Group (CCCG)-mature B-cell non-Hodgkin lymphoma (BNHL)-2015 protocol from June 1, 2015, to December 1, 2022, were collected from three tertiary medical centers in China...
March 15, 2024: Heliyon
https://read.qxmd.com/read/38490295/long-term-follow-up-of-abatacept-post-transplantation-cyclophosphamide-and-sirolimus-abacys-based-haploidentical-transplantation-in-younger-patients-with-nonmalignant-diseases
#22
JOURNAL ARTICLE
Sarita Rani Jaiswal, Mahak Agarwal, Gitali Bhagawati, Bhudev Chandra Das, Prakash Baligar, Manoj Garg, Subhrajit Biswas, Suparno Chakrabarti
BACKGROUND: Haploidentical (Haplo) HCT for nonmalignant diseases (NMD) faces inherent challenges of both alloreactivity and graft failure. Building upon promising results from pilot studies, where abatacept was combined with post-transplantation cyclophosphamide (PTCy) and sirolimus (AbaCyS) in younger NMD patients undergoing haplo-HCT, we present the long-term outcomes of this protocol. STUDY DESIGN: On the back of uniform disease-specific conditioning regimens containing ATG (4...
March 13, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38487112/general-population-awareness-of-primary-immune-deficiency-disease-in-children-in-the-arar-region-saudi-arabia
#23
JOURNAL ARTICLE
Safya E Esmaeel, Hassan T Mohamed, Reef A Alshammari, Israa S Alanazi, Naseem D Aleawaili, Fai S Alanazi
Background Primary immunodeficiency disorders (PIDD) are of various types and severities, and they are associated with a delay in diagnosis. Early diagnosis of PIDD helps to improve the quality of life of affected children and prevent permanent consequences such as organ damage. Hence, awareness of PIDD is a must in the community to aid in early detection. Objectives The study aims to investigate the general population's awareness of PIDD in children in Arar, Northern Saudi Arabia. Methods A cross-sectional design was utilized to determine the awareness of PIDD in children in Arar, Northern Saudi Arabia...
February 2024: Curēus
https://read.qxmd.com/read/38485907/description-of-a-novel-pathogenic-variant-in-the-arpc1b-and-a-severe-allergy-in-two-infants
#24
JOURNAL ARTICLE
Oscar Zaveleta Martínez, Ana Eunice Fregoso-Zuñiga, Cielo Razo Requena, Sara Espinosa Padilla, Lzbeth Blancas Galicia
Actinrelated protein 2/3 complex subunit 1B (ARPC1B) deficiency is an inborn error of immunity (IEI) characterized by a combination of immunodeficiency and immune dysregulation and classified as an IEI with allergic manifestations. Here, we describe two patients with pathogenic variants in the ARPC1B gene. The first patient presented with eczema and bronchospasm at six months of age. The second patient presented with eczema and milk protein allergy at five months of age. The c.899_944 (p.Glu300Glyfs*7) pathogenic variant was previously described, whereas the c...
February 11, 2024: Iranian Journal of Allergy, Asthma, and Immunology
https://read.qxmd.com/read/38482459/accessibility-to-plasma-derived-medicinal-products-in-malaysia-the-challenges-faced-by-patients-with-inborn-errors-of-immunity
#25
JOURNAL ARTICLE
Bruce Wee Diong Lim, Amir Hamzah Abdul Latiff
Inborn errors of immunity (IEI) (also known as primary immunodeficiencies) is an umbrella term for a growing group of over 450 different disorders that are characterized by defects in some of the components of the immune system. IEI are chronic diseases of genetic origin that render individuals suffering from them susceptible to infections. The mainstay of treatments for most patients with IEI, that is, predominantly antibody deficiencies is immunoglobulin replacement therapy (IRT), which is commonly delivered intravenously...
March 2024: Asia Pacific Allergy
https://read.qxmd.com/read/38482457/the-treatment-efficacy-of-dupilumab-in-autosomal-dominant-hyper-immunoglobulin-e-syndrome-with-severe-atopic-dermatitis
#26
Weifeng Li, Qiqi Qi, Weipeng Wang, Dongqin Li
Hyper-immunoglobulin E syndrome (HIES) is a primary immunodeficiency disease characterized by atopic dermatitis, recurrent skin and lung infections, and significantly elevated serum immunoglobulin E levels. Autosomal dominant and loss-of-function pathogenic variants in the STAT3 gene are the most common causes of the disease and studies have shown that the presence of IL-4 receptor (IL-4R) is upregulated in patients with dominant-negative mutations in the STAT3 gene expression. Dupilumab is a monoclonal antibody that targets the IL-4α receptor and improves the symptoms of atopic dermatitis by inhibiting IL-4 and IL-13...
March 2024: Asia Pacific Allergy
https://read.qxmd.com/read/38474381/gene-signature-of-regulatory-t-cells-isolated-from-children-with-selective-iga-deficiency-and-common-variable-immunodeficiency
#27
JOURNAL ARTICLE
Magdalena Rutkowska-Zapała, Agnieszka Grabowska-Gurgul, Marzena Lenart, Anna Szaflarska, Anna Kluczewska, Monika Mach-Tomalska, Monika Baj-Krzyworzeka, Maciej Siedlar
Selective IgA deficiency (SIgAD) is the most common form and common variable immunodeficiency (CVID) is the most symptomatic form of predominant antibody deficiency. Despite differences in the clinical picture, a similar genetic background is suggested. A common feature of both disorders is the occurrence of autoimmune conditions. Regulatory T cells (Tregs ) are the major immune cell type that maintains autoimmune tolerance. As the different types of abnormalities of Treg cells have been associated with autoimmune disorders in primary immunodeficiency (PID) patients, in our study we aimed to analyze the gene expression profiles of Treg cells in CVID and SIgAD patients compared to age-matched healthy controls...
February 27, 2024: Cells
https://read.qxmd.com/read/38469307/reduced-toxicity-matched-sibling-bone-marrow-transplant-results-in-excellent-outcomes-for-severe-congenital-neutropenia
#28
JOURNAL ARTICLE
Joseph H Oved, Nora M Gibson, Kimberly Venella, Caitlin W Elgarten, Lisa Wray, Julia T Warren, Timothy S Olson
Severe congenital neutropenia (SCN) is caused by germline mutations, most commonly in ELANE , impacting neutrophil maturation and leading to high risk of life-threatening infections. Most patients with ELANE- mutant SCN can achieve safe neutrophil counts with chronic Granulocyte-Colony Stimulating Factor (G-CSF). However, up to 10% of patients have neutropenia refractory to G-CSF and require allogeneic stem cell transplant. Traditional conditioning for these patients includes busulfan and cyclophosphamide which is associated with significant toxicities...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38465976/pre-existing-immunocompromising-conditions-and-outcomes-of-acute-covid-19-patients-admitted-for-pediatric-intensive-care
#29
JOURNAL ARTICLE
Courtney M Rowan, Brenna LaBere, Cameron C Young, Laura D Zambrano, Margaret M Newhams, Suden Kucukak, Elizabeth R McNamara, Elizabeth H Mack, Julie C Fitzgerald, Katherine Irby, Aline B Maddux, Jennifer E Schuster, Michele Kong, Heda Dapul, Stephanie P Schwartz, Melania M Bembea, Laura L Loftis, Amanda R Kolmar, Christopher J Babbitt, Ryan A Nofziger, Mark W Hall, Shira J Gertz, Natalie Z Cvijanovich, Matt S Zinter, Natasha B Halasa, Tamara T Bradford, Gwenn E McLaughlin, Aalok R Singh, Charlotte V Hobbs, Kari Wellnitz, Mary A Staat, Bria M Coates, Hillary R Crandall, Mia Maamari, Kevin M Havlin, Adam J Schwarz, Christopher L Carroll, Emily R Levy, Kristin L Moffitt, Angela P Campbell, Adrienne G Randolph, Janet Chou
BACKGROUND: We aimed to determine if pre-existing immunocompromising conditions (ICCs) were associated with the presentation or outcome of patients with acute coronavirus disease 2019 (COVID-19) admitted for pediatric intensive care. METHODS: 55 hospitals in 30 U.S. states reported cases through the Overcoming COVID-19 public health surveillance registry. Patients <21 years admitted March 12, 2020-December 30, 2021 to the pediatric intensive care unit (PICU) or high acuity unit for acute COVID-19 were included...
March 11, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38443525/increased-mortality-in-infants-with-abnormal-t-cell-receptor-excision-circles
#30
JOURNAL ARTICLE
Jenny Huang, Ashwin Shankar, Isabel Hurden, Ronald Thomas, Joseph Hill, Divya Seth, Elizabeth Secord, Pavadee Poowuttikul
BACKGROUND: T-Cell Receptor Excision Circles based newborn screening (TREC-NBS) allows for early detection of T-cell lymphopenia in infants with primary immunodeficiency disorders (PIDD). The utility of abnormal TREC-NBS in infants without PIDD is not well studied. We sought to evaluate the association of abnormal TREC-NBS with mortality. METHODS: 365,207 TREC-NBS from October 2011 to December 2014 were reviewed. 467 newborns had abnormal screens and did not meet the criteria for a PIDD diagnosis...
March 5, 2024: Pediatric Research
https://read.qxmd.com/read/38442908/cxcr4-whim-syndrome-is-a-cancer-predisposition-condition-for-virus-induced-malignancies
#31
JOURNAL ARTICLE
Clémentine Moulin, Blandine Beaupain, Felipe Suarez, Yves Bertrand, Sarah Cohen Beaussant, Alain Fischer, Julie Durin, Dana Ranta, Marion Espéli, Françoise Bachelerie, Christine Bellanné-Chantelot, Thierry Molina, Jean François Emile, Karl Balabanian, Claire Deback, Jean Donadieu
Warts, hypogammaglobulinaemia, infections and myelokathexis syndrome (WHIMS) is a rare combined primary immunodeficiency caused by the gain of function of the CXCR4 chemokine receptor. We present the prevalence of cancer in WHIMS patients based on data from the French Severe Chronic Neutropenia Registry and an exhaustive literature review. The median follow-up of the 14 WHIMS 'patients was 28.5 years. A central review and viral evaluation of pathological samples were organized, and we conducted a thorough literature review to identify all reports of WHIMS cases...
March 5, 2024: British Journal of Haematology
https://read.qxmd.com/read/38439946/natural-language-processing-of-clinical-notes-enables-early-inborn-error-of-immunity-risk-ascertainment
#32
JOURNAL ARTICLE
Kirk Roberts, Aaron T Chin, Klaus Loewy, Lisa Pompeii, Harold Shin, Nicholas L Rider
BACKGROUND: There are now approximately 450 discrete inborn errors of immunity (IEI) described; however, diagnostic rates remain suboptimal. Use of structured health record data has proven useful for patient detection but may be augmented by natural language processing (NLP). Here we present a machine learning model that can distinguish patients from controls significantly in advance of ultimate diagnosis date. OBJECTIVE: We sought to create an NLP machine learning algorithm that could identify IEI patients early during the disease course and shorten the diagnostic odyssey...
May 2024: J Allergy Clin Immunol Glob
https://read.qxmd.com/read/38430844/baseline-immune-status-and-the-effectiveness-of-response-to-enteral-nutrition-among-icu-patients-with-covid-19-an-observational-retrospective-study
#33
JOURNAL ARTICLE
Yao Yin, Yijing Li, Yan Liu, Chaofeng Fan, Yan Jiang
OBJECTIVES: This study aimed to compare how immunocompromised and immunocompetent patients responded differently to enteral nutrition (EN) support in intensive care units (ICUs) during the COVID-19 pandemic, including serum nutritional biomarkers, inflammatory biomarkers, gastrointestinal (GI) intolerance symptoms, and clinical outcomes. METHODS: An observational, retrospective study was conducted in the ICUs of a teaching hospital in southwest China. We recruited a convenience sample of 154 patients between December 2022 and February 2023...
February 8, 2024: Nutrition
https://read.qxmd.com/read/38423196/a-large-deletion-in-a-non-coding-regulatory-region-leads-to-nfkb1-haploinsufficiency-in-two-adult-siblings
#34
JOURNAL ARTICLE
Mathieu Fusaro, Cyrille Coustal, Laura Barnabei, Quentin Riller, Marion Heller, Duong Ho Nhat, Cécile Fourrage, Sophie Rivière, Frédéric Rieux-Laucat, Alexandre Thibault Jacques Maria, Capucine Picard
Mutations in NFkB pathway genes can cause inborn errors of immunity (IEI), with NFKB1 haploinsufficiency being a significant etiology for common variable immunodeficiency (CVID). Indeed, mutations in NFKB1 are found in 4 to 5% of in European and United States CVID cohorts, respectively; CVID representing almost ¼ of IEI patients in European countries registries. This case study presents a 49-year-old patient with respiratory infections, chronic diarrhea, immune thrombocytopenia, hypogammaglobulinemia, and secondary lymphoma...
April 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38414825/gene-editing-based-targeted-integration-for-correction-of-wiskott-aldrich-syndrome
#35
JOURNAL ARTICLE
Melissa Pille, John M Avila, So Hyun Park, Cuong Q Le, Haipeng Xue, Filomeen Haerynck, Lavanya Saxena, Ciaran Lee, Elizabeth J Shpall, Gang Bao, Bart Vandekerckhove, Brian R Davis
Wiskott-Aldrich syndrome (WAS) is a severe X-linked primary immunodeficiency resulting from a diversity of mutations distributed across all 12 exons of the WAS gene. WAS encodes a hematopoietic-specific and developmentally regulated cytoplasmic protein (WASp). The objective of this study was to develop a gene correction strategy potentially applicable to most WAS patients by employing nuclease-mediated, site-specific integration of a corrective WAS gene sequence into the endogenous WAS chromosomal locus. In this study, we demonstrate the ability to target the integration of WAS 2-12 -containing constructs into intron 1 of the endogenous WAS gene of primary CD34+ hematopoietic stem and progenitor cells (HSPCs), as well as WASp-deficient B cell lines and WASp-deficient primary T cells...
March 14, 2024: Molecular Therapy. Methods & Clinical Development
https://read.qxmd.com/read/38411715/psychosocial-evaluation-of-adults-with-primary-immunodeficiency
#36
JOURNAL ARTICLE
Reyhan Gumusburun, Sevgi Altay, Hasancan Cengiz, Gulendam Hakverdioglu Yont, Ozlem Kuman Tuncel, Omur Ardeniz
PURPOSE: Primary immunodeficiency disorder (PID) is a heterogeneous group of diseases characterized by immune dysregulation and increased susceptibility to infections, with various cognitive, emotional, behavioral, and social effects on patients. This study aimed to evaluate loneliness, social adaptation, anxiety, and depression and to identify associated factors in adults with immunodeficiency. METHODS: A cross-sectional study in Turkey (Feb-Aug 2022) obtained sociodemographic data from patient records...
February 27, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38405733/hiv-1-mediated-cortical-actin-disruption-mirrors-arp2-3-defects-found-in-primary-t-cell-immunodeficiencies
#37
Jacqueline M Crater, Daniel Dunn, Douglas F Nixon, Robert L Furler O'Brien
During cell movement, cortical actin balances mechanical and osmotic forces to maintain cell function while providing the scaffold for cell shape. Migrating CD4 + T cells have a polarized structure with a leading edge containing dynamic branched and linear F-actin structures that bridge intracellular components to surface adhesion molecules. These actin structures are complemented with a microtubular network beaded with membrane bound organelles in the trailing uropod. Disruption of actin structures leads to dysregulated migration and changes in morphology of affected cells...
February 15, 2024: bioRxiv
https://read.qxmd.com/read/38404952/a-case-of-naganishial-pleuritis-in-a-kidney-transplant-recipient
#38
Tanapat Tassaneeyasin, Dararat Eksombatchai, Prawat Chantharit, Arunee Singhsnaeh, Viboon Boonsarngsuk
The Naganishia species is a mycosis , previously classified as a non- neoformans Cryptococcus species. The increased number of naganishial infections occurs predominantly in immunocompromised conditions, especially in people living with HIV with low CD4 cell count, primary immunodeficiencies, and iatrogenic immunosuppression. The lungs can serve as the primary site of infection, leading to various pulmonary manifestations. However, naganishial pleural effusions are unrecognized and challenged in diagnosis because of their presentation, which can mimic tuberculous pleural effusion...
February 2024: Respirology Case Reports
https://read.qxmd.com/read/38404734/wiskott-aldrich-syndrome-a-new-synonym-mutation-in-the-was-gene
#39
JOURNAL ARTICLE
Yuxin Sun, Xiaomin Song, Hua Pan, Xiaoxuan Li, Lirong Sun, Liang Song, Fei Ma, Junnan Hao
Wiskott-Aldrich syndrome (WAS) is a rare X-linked recessive primary immunodeficiency disorder. Mutations in the WAS gene are considered to be the primary cause of WAS. In this work, we report a boy who presented with intracranial hemorrhage (ICH) as an initial symptom and detects a novel pathogenic synonymous mutation in his WAS gene. His mother was a carrier of the mutant gene. The mutation, located at position c.273 (c.273 G>A) in exon 2, is a synonym mutation and predicted to affect protein expression by disrupting gene splicing...
February 2024: Intractable & Rare Diseases Research
https://read.qxmd.com/read/38396459/validation-of-artificial-intelligence-ai-assisted-flow-cytometry-analysis-for-immunological-disorders
#40
JOURNAL ARTICLE
Zhengchun Lu, Mayu Morita, Tyler S Yeager, Yunpeng Lyu, Sophia Y Wang, Zhigang Wang, Guang Fan
Flow cytometry is a vital diagnostic tool for hematologic and immunologic disorders, but manual analysis is prone to variation and time-consuming. Over the last decade, artificial intelligence (AI) has advanced significantly. In this study, we developed and validated an AI-assisted flow cytometry workflow using 379 clinical cases from 2021, employing a 3-tube, 10-color flow panel with 21 antibodies for primary immunodeficiency diseases and related immunological disorders. The AI software (DeepFlow™, version 2...
February 14, 2024: Diagnostics
keyword
keyword
57335
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.